TAKEDA GMBH

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 76179
 
  
 
C07D HETEROCYCLIC COMPOUNDS 36126
 
  
 
C07K PEPTIDES 8128
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 742
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 689
 
  
 
B65D CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES 494
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 3135
 
  
 
C07J STEROIDS217
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 2123
 
  
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 1139

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2016/0362,475 UTI FUSION PROTEINSFeb 23, 15Dec 15, 16[C07K]
2016/0355,584 ANTIBODIES NEUTRALIZING GM-CSF FOR USE IN THE TREATMENT OF RHEUMATOID ARTHRITIS OR AS ANALGESICSSep 01, 14Dec 08, 16[C07K]
2016/0324,723 PHARMACEUTICAL PRODUCT FOR INJECTIONJun 27, 16Nov 10, 16[A61J, A61K, B65D]
2016/0022,585 FORMULATION OF AN ANTIBODY AND USE THEREOFMar 17, 14Jan 28, 16[A61K, C07K]
2015/0266,965 Method for Preparation of a High Concentration Liquid Formulation of an AntibodyOct 31, 13Sep 24, 15[C07K]
2014/0120,086 METHOD FOR PREPARATION OF A HIGH CONCENTRATION LIQUID FORMULATION OF AN ANTIBODYOct 31, 13May 01, 14[A61K]
2012/0083,512 PHARMACEUTICAL PRODUCT FOR INJECTIONOct 14, 11Apr 05, 12[A61K, A61P, B65D]
2004/0018,249 Process for the rehydration of magaldrate powderAug 25, 03Jan 29, 04[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9919051 Liquid formulation comprising GM-CSF neutralizing compoundOct 31, 13Mar 20, 18[A61K, C07K]
9856310 UTI fusion proteinsFeb 23, 15Jan 02, 18[A61K, C07K]
9833410 Lyophilized formulation comprising GM-CSF neutralizing compoundOct 31, 13Dec 05, 17[A61K, C07K]
9387205 Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitorsAug 25, 15Jul 12, 16[A61K, A01N, C07D]
9340522 Pyrazolone-derivatives and their use as PDE-4 inhibitorsNov 15, 13May 17, 16[C07D]
9309187 EP2 receptor agonistsApr 30, 13Apr 12, 16[A61K, C07D, C07C]
9149479 Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitorsOct 07, 14Oct 06, 15[A61K, A01N, C07D]
9090597 Pyrazolone derivatives as PDE4 inhibitorsAug 29, 14Jul 28, 15[A61K, C07D]
8883818 Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitorsApr 30, 13Nov 11, 14[A61K, A01N, C07D]
8865745 Pyrazolone derivatives as PDE4 inhibitorsSep 14, 12Oct 21, 14[A61K, A01N, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0339,010 Treatment of Partly Controlled or Uncontrolled Severe AsthmaAbandonedJan 20, 15Nov 24, 16[A61K]
2014/0112,945 NOVEL PHTHALAZINONE-PYRROLOPYRIMIDINECARBOXAMIDE DERIVATIVESAbandonedJun 12, 12Apr 24, 14[A61K, C07D]
2014/0113,877 NOVEL 3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO[4,3-C] ISOQUINOLINE COMPOUNDSAbandonedJun 12, 12Apr 24, 14[A61K, C07D]
8465767 Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazolesExpiredMay 21, 08Jun 18, 13[A61K]
2013/0131,123 Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As ExcipientAbandonedJan 11, 13May 23, 13[A61K]
8324404 3-thia-10-aza-phenanthrene derivativesExpiredMay 28, 09Dec 04, 12[C07D]
8278300 Use for PDE5 inhibitorsExpiredJan 04, 10Oct 02, 12[A61K, A01N]
2012/0196,867 COMPOSITION COMPRISING A PDE4 INHIBITOR AND A PDE5 INHIBITORAbandonedApr 12, 12Aug 02, 12[A61K, A61P]
8198295 BenzonaphthyridinesExpiredSep 23, 08Jun 12, 12[A61K, C07D]
2012/0129,817 COMBINATION TREATMENT FOR DIABETES MELLITUSAbandonedFeb 01, 12May 24, 12[A61K, A61P]
8106047 TriazolophthalazinesExpiredJan 04, 06Jan 31, 12[A61K, C07D]
2011/0313,005 TOPICALLY APPLICABLE PHARMACEUTICAL PREPARATIONAbandonedAug 26, 11Dec 22, 11[A61K, A61P]
2011/0108,027 FILTERING DEVICE, METHOD FOR FILTERING OF A FLUID, AND USE OF THE FILTERING DEVICEAbandonedJul 21, 09May 12, 11[A61M, B01D]
2011/0060,016 Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipientAbandonedSep 07, 10Mar 10, 11[A61K, A61P]
2010/0120,737 Amorphous ciclesonideAbandonedNov 10, 08May 13, 10[A61K, A61P, C07J]
7671050 TriazolophthalazinesExpiredJan 04, 06Mar 02, 10[A61K, C07D, A61P]
7666872 Use for PDE5 inhibitorsExpiredMar 03, 05Feb 23, 10[A61K]
2010/0022,779 Isotopically substituted proton pump inhibitorsAbandonedJul 21, 09Jan 28, 10[C07D]
2010/0010,047 Isotopically substituted proton pump inhibitorsAbandonedAug 31, 09Jan 14, 10[A61K, C07D, A61P]
7601737 Isotopically substituted proton pump inhibitorsExpiredDec 12, 07Oct 13, 09[A61K, C07D]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.